PL327831A1 - Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms - Google Patents

Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms

Info

Publication number
PL327831A1
PL327831A1 PL97327831A PL32783197A PL327831A1 PL 327831 A1 PL327831 A1 PL 327831A1 PL 97327831 A PL97327831 A PL 97327831A PL 32783197 A PL32783197 A PL 32783197A PL 327831 A1 PL327831 A1 PL 327831A1
Authority
PL
Poland
Prior art keywords
diphenylchromanes
treating
production
application
menopause symptoms
Prior art date
Application number
PL97327831A
Inventor
Michael Shalmi
Niels Korsgaard
Birgitte Hjort Guldhammer
James Robertson Piggott
Virender Mohan Labroo
Steven Bain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL327831A1 publication Critical patent/PL327831A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
PL97327831A 1996-01-11 1997-01-09 Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms PL327831A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US983496P 1996-01-11 1996-01-11
US67826196A 1996-07-11 1996-07-11

Publications (1)

Publication Number Publication Date
PL327831A1 true PL327831A1 (en) 1999-01-04

Family

ID=26679921

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97327831A PL327831A1 (en) 1996-01-11 1997-01-09 Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms

Country Status (12)

Country Link
EP (1) EP0873120A1 (en)
JP (1) JP2000506505A (en)
KR (1) KR19990077156A (en)
AU (1) AU1367297A (en)
BR (1) BR9706967A (en)
CA (1) CA2241623A1 (en)
CZ (1) CZ217298A3 (en)
HU (1) HUP9902683A3 (en)
IL (1) IL124882A0 (en)
NO (1) NO983178L (en)
PL (1) PL327831A1 (en)
WO (1) WO1997025035A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DK1246814T3 (en) * 1999-12-30 2005-05-30 Signal Pharm Llc Compounds and Methods for Modulation of Estrogen Receptors
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
ATE532777T1 (en) 2004-09-21 2011-11-15 Marshall Edwards Inc SUBSTITUTED CHROMEDER DERIVATIVES, MEDICATIONS AND APPLICATIONS IN THERAPY
WO2006042409A1 (en) 2004-10-20 2006-04-27 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
JP5558358B2 (en) 2007-10-16 2014-07-23 レプロス セラピューティクス インコーポレイティド TRANS-clomiphene for metabolic syndrome
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR20130031339A (en) 2010-06-16 2013-03-28 앙도르쉐르슈 인코포레이티드 Methods of treating or preventing estrogen-related diseases
JP6013349B2 (en) 2010-11-01 2016-10-25 メイ ファーマ, インク.Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
CA2865234A1 (en) 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
AU2015213484B2 (en) 2014-02-07 2015-11-05 Kazia Therapeutics Limited Functionalised benzopyran compounds and use thereof
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
ES2877712T3 (en) 2015-02-02 2021-11-17 Mei Pharma Inc Combination therapies for use in the treatment of breast cancer
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
EP0873120A1 (en) 1998-10-28
NO983178L (en) 1998-07-10
HUP9902683A3 (en) 2001-08-28
CZ217298A3 (en) 1999-01-13
KR19990077156A (en) 1999-10-25
HUP9902683A2 (en) 2001-04-28
CA2241623A1 (en) 1997-07-17
WO1997025035A1 (en) 1997-07-17
IL124882A0 (en) 1999-01-26
JP2000506505A (en) 2000-05-30
AU1367297A (en) 1997-08-01
BR9706967A (en) 1999-05-04

Similar Documents

Publication Publication Date Title
PL327831A1 (en) Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms
PL330119A1 (en) Substituted 3,5-diphenyl-1,2,4-triazoles and their application as metals-chelating pharmaceutic agents
ZA942571B (en) 1,5 benzodiazepine derivatives
IL122987A0 (en) Novel 2,3-dioso-1, 2, 3, 4-tetrahydro-quinoxalinyl derivatives
HU9502684D0 (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkane-carboxylic acid derivatives
ZA95462B (en) Substitute 1,2,3,4-tetrahydro -5-nitro-pyrimidines
EP0927038A4 (en) P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
EP0845457A4 (en) 2,2-dideutero-5-aminolevulinic acid
AU3325495A (en) 1,2-disubstituted aromatic chelates
EP0742849A4 (en) Surface treatment agent for zinciferous-plated steel
AP9500731A0 (en) 1,5 benzodiazepine derivatives
PL321585A1 (en) Personal washing agent inn the form of a bar
EP0612529A3 (en) Therapeutic agent for NIDDM.
SG65043A1 (en) Process for purifying crude 1,4-butanediol
ZA971716B (en) 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease
EP0736508A4 (en) Process for purifying 1,1,1,3,3-pentafluoro-2,3-dichloropropane
CZ71095A3 (en) Track ballastway treating machine
KR19987002519A (en) Process for subsequent codensation of polycondensates , in particular of poyamide 6.6
PL317190A1 (en) Pharmaceutic composition for treating glaucoma
ZA93639B (en) New 4-cinnolinyl- and 4 naphthyridinyl-dihydropyridines, processes for their use in medicaments.
AU5495398A (en) Idebenone containing combination agent for treating alzheimer's disease
ZA9510694B (en) 1 3 4-oxadiazine derivatives
HK1005625A1 (en) Compatibilising agents
HU9402990D0 (en) Lock-system for safety locks
GB9513818D0 (en) 7,7-Disubstituted cephem-4-ketones